EE200200401A - Drospirenoon hormoonasendusraviks - Google Patents

Drospirenoon hormoonasendusraviks

Info

Publication number: EE200200401A
Authority: EE; Estonia
Prior art keywords: drospirenone; composition; replacement therapy; hormone replacement; further embodiment
Prior art date: 2000-01-18

Application number

EEP200200401A

Other languages

English (en)

Inventor

Heil Wolfgang

Hilmann J�rgen

Lipp Ralph

Sch�rmann Rolf

Original Assignee

Schering Aktiengesellschaft

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-01-18

Filing date

2001-01-18

Publication date

2003-10-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26071749&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE200200401(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-01-18 Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft

2003-10-15 Publication of EE200200401A publication Critical patent/EE200200401A/et

2012-04-16 Publication of EE05533B1 publication Critical patent/EE05533B1/et

Links

METQSPRSQINEEU-UHFFFAOYSA-N dihydrospirorenone Natural products CC12CCC(C3(CCC(=O)C=C3C3CC33)C)C3C1C1CC1C21CCC(=O)O1 METQSPRSQINEEU-UHFFFAOYSA-N 0.000 title abstract 7
METQSPRSQINEEU-HXCATZOESA-N drospirenone Chemical compound C([C@]12[C@H]3C[C@H]3[C@H]3[C@H]4[C@@H]([C@]5(CCC(=O)C=C5[C@@H]5C[C@@H]54)C)CC[C@@]31C)CC(=O)O2 METQSPRSQINEEU-HXCATZOESA-N 0.000 title abstract 7
229960004845 drospirenone Drugs 0.000 title abstract 7
238000002657 hormone replacement therapy Methods 0.000 title 1
239000000203 mixture Substances 0.000 abstract 4
238000004090 dissolution Methods 0.000 abstract 1
239000003937 drug carrier Substances 0.000 abstract 1
238000009506 drug dissolution testing Methods 0.000 abstract 1
229940011871 estrogen Drugs 0.000 abstract 1
239000000262 estrogen Substances 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000002245 particle Substances 0.000 abstract 1
239000000546 pharmaceutical excipient Substances 0.000 abstract 1
238000003756 stirring Methods 0.000 abstract 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Endocrinology (AREA)
Epidemiology (AREA)
Neurosurgery (AREA)
Diabetes (AREA)
Physical Education & Sports Medicine (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Dermatology (AREA)
Reproductive Health (AREA)
Psychiatry (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Pain & Pain Management (AREA)
Tropical Medicine & Parasitology (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Medical Preparation Storing Or Oral Administration Devices (AREA)

EEP200200401A 2000-01-18 2001-01-18 Farmatseutiline kompositsioon ja preparaat, mis sisaldab mikroniseeritud drospirenooni ja strogeeni ning nende kasutamine EE05533B1 (et)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US48402600A	2000-01-18	2000-01-18
EP00200183		2000-01-18
PCT/IB2001/000041 WO2001052857A1 (en)	2000-01-18	2001-01-18	Drospirenone for hormone replacement therapy

Publications (2)

Publication Number	Publication Date
EE200200401A true EE200200401A (et)	2003-10-15
EE05533B1 EE05533B1 (et)	2012-04-16

Family

ID=26071749

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200200401A EE05533B1 (et)	2000-01-18	2001-01-18	Farmatseutiline kompositsioon ja preparaat, mis sisaldab mikroniseeritud drospirenooni ja strogeeni ning nende kasutamine

Country Status (30)

Country	Link
EP (2)	EP1257280B1 (et)
JP (2)	JP5128743B2 (et)
KR (2)	KR100747965B1 (et)
CN (2)	CN101934078A (et)
AT (2)	ATE305789T1 (et)
AU (3)	AU2001225413B2 (et)
BG (1)	BG65849B1 (et)
BR (1)	BR0107683A (et)
CA (1)	CA2394165C (et)
CY (1)	CY1109567T1 (et)
CZ (1)	CZ20022411A3 (et)
DE (2)	DE60139907D1 (et)
DK (2)	DK1611892T3 (et)
EE (1)	EE05533B1 (et)
ES (2)	ES2332226T3 (et)
HK (1)	HK1047248B (et)
HU (1)	HUP0204291A3 (et)
IL (3)	IL150775A0 (et)
ME (1)	ME00292B (et)
MX (1)	MXPA02006613A (et)
NO (1)	NO335570B1 (et)
NZ (1)	NZ520630A (et)
PL (1)	PL201878B1 (et)
PT (1)	PT1611892E (et)
RS (1)	RS52149B (et)
RU (2)	RU2275198C2 (et)
SI (2)	SI1611892T1 (et)
SK (2)	SK288129B6 (et)
WO (1)	WO2001052857A1 (et)
ZA (2)	ZA200206551B (et)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK1380301T3 (da) *	1999-08-31	2009-04-20	Bayer Schering Pharma Ag	Farmaceutisk sammensætning af ethinylestradiol og drospirenon til anvendelse som svangerskabsforebyggende middel
EP1216713A1 (en) *	2000-12-20	2002-06-26	Schering Aktiengesellschaft	Compositions of estrogen-cyclodextrin complexes
WO2003006027A1 (en)	2001-07-13	2003-01-23	Schering Aktiengesellschaft	Combination of drospirenone and an estrogen sulphamate for hrt
AU2003220171A1 (en) *	2002-03-11	2003-09-29	Janssen Pharmaceutica N.V.	Continuous sulfatase inhibiting progestogen hormone replacement therapy
BR0309780A (pt) *	2002-04-26	2005-03-22	Schering Aktiengellschaft	Tratamento da hipertensão em mulheres recebendo terapia de reposição hormonal
WO2004041288A1 (en) *	2002-11-05	2004-05-21	Schering Aktiengesellschaft	Hormone replacement therapy with drospirenone
US7786101B2 (en)	2002-11-05	2010-08-31	Bayer Schering Pharma Ag	Cardiovascular protection using anti-aldosteronic progestins
WO2004041289A1 (en) *	2002-11-05	2004-05-21	Schering Aktiengesellschaft	Cardiovascular protection using anti-aldosteronic progestins
DE602005014227D1 (de) *	2004-03-10	2009-06-10	Bayer Schering Pharma Ag	Zusammensetzungen aus drospirenon in molekularer dispersion
MY142989A (en)	2004-03-10	2011-02-14	Bayer Schering Pharma Ag	Stabilised supersaturated solids of lipophilic drugs
DE102004023984A1 (de) *	2004-05-14	2005-12-08	Hf Arzneimittelforschung Gmbh	Filmförmiges, oral zu verabreichendes Arzneimittel, enthaltend Estriol
US8022053B2 (en)	2004-11-02	2011-09-20	Bayer Schering Pharma Aktiengesellschaft	Oral solid dosage forms containing a low dose of estradiol
JP2009501722A (ja) *	2005-07-15	2009-01-22	バイエル・シエーリング・ファーマアクチエンゲゼルシャフト	ドロスピレノン含有経皮用薬剤供給装置及びその供給方法
DE102005056527A1 (de) *	2005-11-25	2007-07-12	Grünenthal GmbH	Verwendung einer Kombination aus Ethinylestradiol und Chlormadinonacetat zur Herstellung eines Arzneimittels
US8617597B2 (en)	2006-07-06	2013-12-31	Bayer Intellectual Property Gmbh	Pharmaceutical composition containing a tetrahydrofolic acid
CN101489563A (zh) *	2006-07-06	2009-07-22	拜耳先灵医药股份有限公司	用于避孕和预防先天性畸形风险的药物制剂
DE102007011105A1 (de)	2007-03-02	2008-09-04	Bayer Schering Pharma Aktiengesellschaft	Mineralcorticoid-Rezeptor-Antagonisten zur Behandlung von Endometriose
CN101623287B (zh) *	2008-07-07	2012-02-08	天津金耀集团有限公司	一种屈螺酮类似物的治疗更年期综合症的药物组合物
ES2344675B1 (es) *	2008-12-19	2011-04-28	Italfarmaco, S.A.	Uso de estriol en la preparacion de una formulacion farrmaceutica para el tratamiento de atrofia vaginal en mujeres con riesgo de patologiacardiovascular.
UY32836A (es)	2009-08-12	2011-03-31	Bayer Schering Pharma Ag	Partículas estabilizadas que comprenden 5-metil-(6s)-tetrahidrofolato
KR20130097073A (ko) *	2010-04-15	2013-09-02	바이엘 인텔렉쳐 프로퍼티 게엠베하	초저-용량의 ｈｒｔ용 고체 경구 투여 형태
JP5852639B2 (ja) *	2010-04-15	2016-02-03	バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒＩｎｔｅｌｌｅｃｔｕａｌＰｒｏｐｅｒｔｙＧｍｂＨ	Ｈｒｔのための低用量固体経口投与形態
US10849857B2 (en)	2010-07-28	2020-12-01	Laboratorios Leon Farma Sa	Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
AR081670A1 (es)	2010-06-29	2012-10-10	Leon Farma Sa Lab	Composicion farmaceutica que comprende drospirenona y kit anticonceptivo
US11351122B1 (en)	2010-07-28	2022-06-07	Laboratorios Leon Farma Sa	Synthetic progestogens and pharmaceutical compositions comprising the same
US9603860B2 (en)	2010-07-28	2017-03-28	Laboratorios Leon Farma Sa	Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
BR112014010590A2 (pt)	2011-11-04	2017-05-02	Bayer Ip Gmbh	18-metil-6,7-metilen-3-oxo-17-pregn-4-eno-21,17?-carbolactonas, preparações farmacêuticas contendo os compostos mencionados e seu uso na terapia da endometriose
TW201350122A (zh) *	2012-04-23	2013-12-16	Bayer Pharma AG	１８－甲基－１５β，１６β－亞甲基－１９－降－２０－螺氧－４－烯－３－酮的子宮內用途，包含１８－甲基－１５β，１６β－亞甲基－１９－降－２０－螺氧－４－烯－３－酮的子宮內系統，及其於避孕及婦科治療之用途
UA115576C2 (uk)	2012-12-06	2017-11-27	Байєр Фарма Акцієнгезелльшафт	Похідні бензимідазолу як антагоністи ер4
TW201607943A (zh)	2013-12-19	2016-03-01	拜耳製藥公司	作為ｅｐ４配體之新穎苯并咪唑衍生物
EP3701944B1 (en)	2015-06-18	2021-12-08	Estetra SRL	Orodispersible dosage unit containing an estetrol component
CA3178291A1 (en)	2016-08-05	2018-04-12	Estetra Srl	Method for the management of dysmenorrhea and menstrual pain
CN110809473A (zh) *	2017-06-01	2020-02-18	延世大学校产学协力团	用于预防或治疗骨相关疾病的药物组合物
TWI801561B (zh)	2018-04-19	2023-05-11	比利時商依思特拉私人有限責任公司	化合物及其用於緩解絕經相關症狀的用途
EP3781171B1 (en) *	2018-04-19	2022-02-09	Estetra SRL	Compounds and their uses for alleviating menopause-associated symptoms
TWI893101B (zh)	2020-04-16	2025-08-11	比利時商埃斯特拉有限責任公司	具有降低之副作用之避孕組成物
CN115813937B (zh) *	2022-12-01	2025-04-11	南通联亚药业股份有限公司	一种稳定的包含屈螺酮和雌二醇的药物组合物及其制备方法
CN118356456A (zh) *	2024-04-17	2024-07-19	且安生物科技有限责任公司	一种抗炎护巢草本提取制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2652761C2 (de) *	1976-11-16	1985-11-21	Schering AG, 1000 Berlin und 4709 Bergkamen	15,16-Methylen-Spirolactone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE3022337A1 (de) *	1980-06-11	1982-01-07	Schering Ag Berlin Und Bergkamen, 1000 Berlin	Praeparate zur kontrazeption und zur behandlung gynaekologischer stoerungen
JPH07114946B2 (ja) *	1988-10-24	1995-12-13	株式会社奈良機械製作所	難溶性物質の処理方法
JP2859919B2 (ja) *	1990-03-15	1999-02-24	旭化成工業株式会社	難溶性薬物の溶出性改善方法
NL9301562A (nl) *	1993-09-09	1995-04-03	Saturnus Ag	Preparaat voor substitutietherapie.
JPH07112928A (ja) *	1993-10-15	1995-05-02	Freunt Ind Co Ltd	難溶性薬物の溶解性改善方法およびそれにより得られた粒状薬剤
DE4344462C2 (de) *	1993-12-22	1996-02-01	Schering Ag	Zusammensetzung für die Empfängnisverhütung
JP4022269B2 (ja) *	1995-05-26	2007-12-12	協和醗酵工業株式会社	医薬組成物
US5922349A (en) *	1995-09-28	1999-07-13	Schering Aktiengesellschaft	Hormone replacement therapy method and hormone dispenser
PT956024E (pt) *	1996-07-26	2004-10-29	Wyeth Corp	Metodo contraceptivo oral monofasico e estojo ("kit") compreendendo uma combinacao de uma progestina e estrogenio
AU3961697A (en) *	1996-07-26	1998-02-20	American Home Products Corporation	Oral contraceptive
DE19633685C1 (de) *	1996-08-12	1997-10-09	Schering Ag	Verfahren zur Herstellung von Drospirenon (6beta,7beta;15 beta,16beta-Dimethyl-en-3-oxo-17alpha-pregn-4-en-21,17-carbolacton, DRSP) sowie 7alpha-(3-Hydroxy-1-propyl)-6beta,7beta;15beta, 16beta-dimethylen-5beta-androstan-3beta,5,17beta-triol (ZK 92836) und 6beta,7beta;15beta,16beta-dimethylen-5beta-hydroxy-3-oxo-17alpha-androstan-21,17-carbolacton (90965) als Zwischenprodukte des Verfahrens
DE19654609A1 (de) *	1996-12-20	1998-06-25	Schering Ag	Therapeutische Gestagene zur Behandlung von Premenstrual Dysphoric Disorder
JPH10182701A (ja) *	1996-12-26	1998-07-07	Sanei Toka Kk	溶出性向上粉末及びその製造方法
US6045829A (en) *	1997-02-13	2000-04-04	Elan Pharma International Limited	Nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizers
DK1380301T3 (da) *	1999-08-31	2009-04-20	Bayer Schering Pharma Ag	Farmaceutisk sammensætning af ethinylestradiol og drospirenon til anvendelse som svangerskabsforebyggende middel

2001
- 2001-01-18 AU AU2001225413A patent/AU2001225413B2/en not_active Expired
- 2001-01-18 RS YU54602A patent/RS52149B/sr unknown
- 2001-01-18 EP EP01900579A patent/EP1257280B1/en not_active Revoked
- 2001-01-18 DK DK05076969T patent/DK1611892T3/da active
- 2001-01-18 PT PT05076969T patent/PT1611892E/pt unknown
- 2001-01-18 PL PL356987A patent/PL201878B1/pl unknown
- 2001-01-18 ME MEP-2008-380A patent/ME00292B/me unknown
- 2001-01-18 KR KR1020027009259A patent/KR100747965B1/ko not_active Expired - Lifetime
- 2001-01-18 SI SI200130947T patent/SI1611892T1/sl unknown
- 2001-01-18 BR BR0107683-3A patent/BR0107683A/pt not_active Application Discontinuation
- 2001-01-18 JP JP2001552904A patent/JP5128743B2/ja not_active Expired - Lifetime
- 2001-01-18 DE DE60139907T patent/DE60139907D1/de not_active Expired - Lifetime
- 2001-01-18 DK DK01900579T patent/DK1257280T3/da active
- 2001-01-18 SK SK5025-2011A patent/SK288129B6/sk not_active IP Right Cessation
- 2001-01-18 HU HU0204291A patent/HUP0204291A3/hu unknown
- 2001-01-18 NZ NZ520630A patent/NZ520630A/en not_active IP Right Cessation
- 2001-01-18 CN CN2010102885016A patent/CN101934078A/zh active Pending
- 2001-01-18 RU RU2002122113/15A patent/RU2275198C2/ru active
- 2001-01-18 CN CN01803878A patent/CN1395488A/zh active Pending
- 2001-01-18 SI SI200130434T patent/SI1257280T1/sl unknown
- 2001-01-18 EP EP05076969A patent/EP1611892B1/en not_active Expired - Lifetime
- 2001-01-18 AT AT01900579T patent/ATE305789T1/de active
- 2001-01-18 ES ES05076969T patent/ES2332226T3/es not_active Expired - Lifetime
- 2001-01-18 HK HK02109001.6A patent/HK1047248B/en not_active IP Right Cessation
- 2001-01-18 ES ES01900579T patent/ES2247054T3/es not_active Expired - Lifetime
- 2001-01-18 EE EEP200200401A patent/EE05533B1/et unknown
- 2001-01-18 CA CA2394165A patent/CA2394165C/en not_active Expired - Lifetime
- 2001-01-18 IL IL15077501A patent/IL150775A0/xx active IP Right Grant
- 2001-01-18 DE DE60113809T patent/DE60113809T2/de not_active Expired - Lifetime
- 2001-01-18 CZ CZ20022411A patent/CZ20022411A3/cs unknown
- 2001-01-18 KR KR1020077010304A patent/KR100913910B1/ko not_active Expired - Lifetime
- 2001-01-18 AT AT05076969T patent/ATE442147T1/de active
- 2001-01-18 MX MXPA02006613A patent/MXPA02006613A/es active IP Right Grant
- 2001-01-18 AU AU2541301A patent/AU2541301A/xx active Pending
- 2001-01-18 WO PCT/IB2001/000041 patent/WO2001052857A1/en not_active Ceased
- 2001-01-18 SK SK1032-2002A patent/SK287719B6/sk not_active IP Right Cessation
2002
- 2002-06-20 NO NO20022966A patent/NO335570B1/no not_active IP Right Cessation
- 2002-07-12 BG BG106915A patent/BG65849B1/bg unknown
- 2002-07-16 IL IL150775A patent/IL150775A/en unknown
- 2002-08-15 ZA ZA2002/06551A patent/ZA200206551B/en unknown
2005
- 2005-09-07 AU AU2005209600A patent/AU2005209600B2/en not_active Expired
- 2005-12-27 RU RU2005140938/15A patent/RU2402331C2/ru active
2006
- 2006-02-13 ZA ZA2006/01285A patent/ZA200601285B/en unknown
2008
- 2008-04-29 IL IL191131A patent/IL191131A/en active IP Right Grant
2009
- 2009-02-12 JP JP2009030542A patent/JP5563227B2/ja not_active Expired - Lifetime
- 2009-12-09 CY CY20091101285T patent/CY1109567T1/el unknown

Also Published As

Publication number	Publication date
ME00292B (me)	2011-05-10
ATE442147T1 (de)	2009-09-15
RU2002122113A (ru)	2004-03-10
BG65849B1 (bg)	2010-03-31
HK1047248A1 (en)	2003-02-14
SI1257280T1 (sl)	2006-02-28
ATE305789T1 (de)	2005-10-15
PT1611892E (pt)	2009-11-20
HUP0204291A2 (hu)	2003-04-28
AU2001225413B2 (en)	2005-06-23
JP5128743B2 (ja)	2013-01-23
RU2005140938A (ru)	2007-07-10
ES2247054T3 (es)	2006-03-01
WO2001052857A1 (en)	2001-07-26
DK1611892T3 (da)	2009-11-02
HUP0204291A3 (en)	2003-05-28
NO20022966L (no)	2002-09-18
RS52149B (sr)	2012-08-31
CZ20022411A3 (cs)	2003-02-12
EP1611892A3 (en)	2006-02-01
ZA200206551B (en)	2006-04-29
EP1611892A2 (en)	2006-01-04
PL201878B1 (pl)	2009-05-29
MEP38008A (en)	2011-02-10
BG106915A (bg)	2003-04-30
CY1109567T1 (el)	2014-08-13
NZ520630A (en)	2004-09-24
BR0107683A (pt)	2002-11-12
KR20070051956A (ko)	2007-05-18
DE60113809T2 (de)	2006-06-22
SK287719B6 (en)	2011-07-06
AU2005209600B2 (en)	2008-08-07
KR100747965B1 (ko)	2007-08-08
ZA200601285B (en)	2008-01-08
DK1257280T3 (da)	2005-12-12
NO20022966D0 (no)	2002-06-20
DE60139907D1 (de)	2009-10-22
AU2541301A (en)	2001-07-31
CA2394165C (en)	2010-04-13
EP1257280A1 (en)	2002-11-20
IL150775A0 (en)	2003-02-12
JP2009120615A (ja)	2009-06-04
SK10322002A3 (sk)	2003-03-04
HK1047248B (en)	2005-12-30
CN1395488A (zh)	2003-02-05
YU54602A (sh)	2006-01-16
EP1611892B1 (en)	2009-09-09
RU2275198C2 (ru)	2006-04-27
CA2394165A1 (en)	2001-07-26
RU2402331C2 (ru)	2010-10-27
IL191131A (en)	2010-12-30
SI1611892T1 (sl)	2010-01-29
KR100913910B1 (ko)	2009-08-26
IL150775A (en)	2008-08-07
JP2003520239A (ja)	2003-07-02
EE05533B1 (et)	2012-04-16
CN101934078A (zh)	2011-01-05
JP5563227B2 (ja)	2014-07-30
ES2332226T3 (es)	2010-01-29
PL356987A1 (en)	2004-07-12
EP1257280B1 (en)	2005-10-05
NO335570B1 (no)	2014-12-29
DE60113809D1 (de)	2006-02-16
SK288129B6 (sk)	2013-10-02
KR20020088066A (ko)	2002-11-25
MXPA02006613A (es)	2003-10-15
AU2005209600A1 (en)	2005-09-29
IL191131A0 (en)	2008-11-03
HK1082433A1 (en)	2006-06-09

Legal Events

Date	Code	Title
2009-08-17	HC1A	Change of owner name
2011-12-15	HC1A	Change of owner name
2012-08-15	HC1A	Change of owner name

Publication	Publication Date	Title
NO20022966L (no)	2002-09-18	Drospirenon for hormonerstatningsterapi
BE2015C026I2 (en)	2018-08-24	2-phenyl-1-[-(2-aminoethoxy)-benzyl -indole in combination with estrogens
EP1598069A3 (en)	2006-04-05	Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
DE69627253T2 (de)	2004-01-29	Fenofibrathaltige neue galenische Arzneizusammensetzungen und ihre Verwendung
CA2366702A1 (en)	2000-10-12	Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
SE0102843L (sv)	2001-10-26	Stabiliserad oral farmaceutisk komposition innehållande jodid och jodat och metod
MY121397A (en)	2006-01-28	Ziprasidone formulations
CA2289202A1 (en)	1998-11-12	Solid pharmaceutical formulations containing a physical mixture of sulfoalkyl ether cyclodextrin and a therapeutic agent
TW367430B (en)	1999-08-21	Copolymers containing N-vinyllactam derivatives, preparation methods thereof and photoresist composition therefrom
AU2002350561A1 (en)	2003-05-06	Novel anti-inflammatory androstane derivatives -17-carboxy-lactone substituted steroids with an aryl-carboxylic ester in position 17.alpha
DE69728914D1 (de)	2004-06-03	Pharmazeutische Zusammensetzung gegen durch Papillomaviren verursachte Tumoren und Infektionen
HK95697A (en)	1997-08-08	5-HT1-like receptor agonist for rectal administration
WO2000054763A3 (en)	2001-09-07	Pharmaceutical compositions comprising polymorphic forms of dehydroepiandrosterone
SK60595A3 (en)	1996-05-08	Pharmaceutical agents containing gemfibrozil
AU2624499A (en)	1999-09-15	Oral compositions at low dosage of cytotoxic proteins
KR970061245A (ko)	1997-09-12	프로제스테론 및 에스트로젠 작동약을 사용한, 뼈 손실 예방용 약학 조성물
Ivashin et al.	1989	Development of addiction to carbophos in the offspring of rats at administration during pregnancy.
TH46567B (th)	2015-10-21	องค์ประกอบของฮอร์โมนซึ่งประกอบด้วยสารประกอบเอสโตรเจนและสารประกอบโปรเจสเตชัน
ES2133052A1 (es)	1999-08-16	Nuevas formulaciones farmaceuticas liquidas para la via oral.